Erika Paradiso, MD
- 3Articles
- 7.4KReads
- 2004–2006Active
- 7Collaborators
About
Erika Paradiso, MD, has published research on the treatment of borderline personality disorder, focusing on the use of quetiapine and oxcarbazepine. Additionally, Paradiso has investigated clinical features and cognitive functions related to age at onset in schizophrenia patients. Her work, published between 2004 and 2006, includes collaborations with authors such as Filippo Bogetto and Silvio Bellino.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
